FRM
CNMD icon

Fox Run Management’s CONMED CNMD Stock Holding History

Fox Run Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,776
Closed -$662K – 985
2026
Q1 		$662K Buy
19,776
+14,691
+289% +$598K 0.12% 323
2025
Q4 		$206K Buy
+5,085
New +$221K 0.03% 798
2024
Q2 		– Sell
-10,014
Closed -$802K – 818
2024
Q1 		$802K Buy
10,014
+7,448
+290% +$664K 0.17% 212
2023
Q4 		$281K Buy
+2,566
New +$265K 0.07% 515

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Fox Run Management's CNMD Position: Q2 2026 in Review

Fox Run Management sold out of CONMED (CNMD) in Q2 2026, closing a stake of 19,776 shares — an estimated $662K sold.

Fox Run Management first reported a position in CNMD in Q4 2023 and held it in 4 quarters. The position peaked at $802K in Q1 2024. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Fox Run Management reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 19,776 CONMED shares in Q2 2026, an estimated $662K.
  • Fox Run Management first reported a position in CONMED in Q4 2023 and held it in 4 quarters.
  • Fox Run Management's CONMED position peaked at $802K in Q1 2024.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.